Health
4 Reasons to Hang On to Your Moderna Stock – Motley Fool
A proposal to nullify intellectual property regarding COVID-19 vaccines seems unlikely to affect Moderna’s bottom line.
Shares of Moderna(NASDAQ:MRNA) and its peers have been under pressure in response to a bomb the Biden administration’s new trade envoy, Katherine Tai, dropped on America’s technology-driven economy. On May 5, Tai voiced support for a World Trade Organization (WTO) proposal that would nullify intellectual property rights in COVID-19 vaccines for Moderna and its peers.
Fortunately for Moderna, the U.S. trade envoy’s position is based on arguments that don’t hold water. Here are four reasons the WTO’s…
-
General11 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General14 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News13 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business11 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher